Featured Research

from universities, journals, and other organizations

Sharp rise in professional queries about harmful effects of 'fat burning' agent

Date:
June 23, 2014
Source:
BMJ-British Medical Journal
Summary:
The number of professional inquiries made to the National Poisons Information Service about the harmful effects of a 'fat burning' agent used by body builders and dieters has risen sharply in the past three years, reveals research. 2,4-Dinitrophenol, or DNP for short, is a synthetic chemical originally used in the manufacture of dyes, wood preservatives, phototographic developers, explosives and insecticides.

The number of professional enquiries made to the National Poisons Information Service about the harmful effects of a 'fat burning' agent used by body builders and dieters has risen sharply in the past three years, reveals research published online in Emergency Medicine Journal.

2,4-Dinitrophenol, or DNP for short, is a synthetic chemical originally used in the manufacture of dyes, wood preservatives, phototographic developers, explosives and insecticides.

It speeds up metabolism and the body's use of fat and glucose stores, and was subsequently developed as a weight loss drug in the US in the 1930s.

But its side effects, which include very high fever and multi organ failure, especially at high doses, prompted US drugs regulator the FDA to ban it for human use in 1938. Although not licensed for medicinal use, it is available on the internet.

In a bid to gauge the prevalence of harm associated with DNP use in the UK, the researchers analysed the phone records of the National Poisons Information Service and online searches of its linked database, TOXBASE, for enquiries about DNP between 2007 and 2013.

The National Poisons Information Service is commissioned by Public Health England and provides phone and online information and clinical advice to healthcare professionals on all aspects of poisoning.

The phone records revealed that 39 enquiries had been made about 30 separate incidents involving 27 men and three women, ranging in age from 15 to 45.

Three cases occurred between 2007 and 2011; five in 2012; and 22 in 2013. A similarly sharp increase was seen in the number of online searches of TOXBASE. These rose from six in 2011 to 35 in 2012, and 331 in 2013.

The most commonly reported symptoms in the phone enquiries included fever (47% of cases), rapid heart rate or tachycardia in 43%, and sweating in 37% of cases.

But nausea or vomiting, skin discolouration or rash, breathing difficulties, abdominal pain, agitation, and headache were also reported.

Five people died, four of whom had taken very high doses of DNP. Three of the deaths occurred in 2013, with the others occurring in 2008 and 2012.

The researchers emphasise that the Poisons Service received more than 50,000 annual phone enquiries during the study period, with the total number of TOXBASE searches amounting to more than 550,000. So enquiries about DNP make up just a small fraction.

Nevertheless, the figures clearly show a sharp rise in the number of enquiries about DNP, they say, in spite of warnings about its harmful side effects, issued by the Food Standards Agency (FSA) in November 2012 and October 2013.

The FSA has been working with police and local authorities to crack down on sales of DNP, say the researchers, but additional steps may be necessary to curb the number of episodes of severe poisoning and associated deaths, they warn.


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. Kamour, N. George, D. Gwynnette, G. Cooper, D. Lupton, M. Eddleston, J. P. Thompson, J. A. Vale, H. K. R. Thanacoody, S. Hill, S. H. L. Thomas. Increasing frequency of severe clinical toxicity after use of 2,4-dinitrophenol in the UK: a report from the National Poisons Information Service. Emergency Medicine Journal, 2014; DOI: 10.1136/emermed-2013-203335

Cite This Page:

BMJ-British Medical Journal. "Sharp rise in professional queries about harmful effects of 'fat burning' agent." ScienceDaily. ScienceDaily, 23 June 2014. <www.sciencedaily.com/releases/2014/06/140623225003.htm>.
BMJ-British Medical Journal. (2014, June 23). Sharp rise in professional queries about harmful effects of 'fat burning' agent. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2014/06/140623225003.htm
BMJ-British Medical Journal. "Sharp rise in professional queries about harmful effects of 'fat burning' agent." ScienceDaily. www.sciencedaily.com/releases/2014/06/140623225003.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins